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Abstract 
We review the current understanding of the myosin heavy chain (MHC) isoforms and show that the mRNA levels 
of smooth muscle (SM)1 and SM2 mimic the expressed levels of SM1 and SM2 protein. The reverse 
transcriptase-polymerase chain reaction technique has been shown to be sufficiently sensitive to examine SM-
MHC expression at the single cell level. Most single smooth muscle cells isolated from adult rabbit carotid 
express both SM1 and SM2. However, expression of these SM-MHC isoforms at the cellular level is nonuniform 
and highly variable. This work provides a foundation for future investigations as to the possible unique 
functional characteristics of the SM-MHC isoforms, SM1 and SM2. This methodology may also prove useful 
when used with mechanical studies to determine the physiological significance of the alternatively spliced 
myosin isoforms, including the SM-MHC-head and LC17 isoforms. 
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Smooth muscle cells are the major cell type present in many body systems (vascular, digestive, respiratory, 
reproductive, urinary, etc.) and make up part of every organ and tissue in the body via the vascular system. The 
importance of the proper functioning of smooth muscle can be appreciated by noting that vascular diseases 
alone account for most morbidity and mortality in the United States. Unfortunately, our understanding of 
smooth muscle function is still rather limited despite the significant progress achieved in the past two decades. 
In this article, we review current literature and work from our laboratory indicating that all smooth muscle cells 
are not the same. This concept is important for further studies because experimental design and interpretation 
may need to be reevaluated to assimilate this hypothesis. 
Arteries have a unique anatomical structure that is generally divided into three main sections: the tunica intima, 
tunica media and the tunica adventitia. The tunica intima is the inner lining of the vessel wall and consists of a 
layer of endothelial cells and a subendothelial layer composed of loose connective tissue and an internal elastic 
lamina in larger arteries. The tunica media consists of circumferentially arranged smooth muscle cells with small 
amounts of connective tissue and proteoglycans. The tunica adventitia, or outer layer, is made up of connective 
tissue and is separated from the media in larger vessels by an external elastic lamina. In healthy vessels, these 
layers remain discrete. 
Smooth muscle (SM) myosin is a hexamer composed of two heavy chains (SM1 and SM2), two regulatory 
(phosphorylatable) light chains (LC20) and two alkali light chains (LC17) (Fig. 1). Burridge and Bray [7]observed two 
myosin heavy chains (MHCs) in chicken gizzard. Rovner et al. [63]first showed that two different isoforms of 
MHC were observed in various SM tissues, with the suggestion that they could be important for the unique 
contractile function present in these cells. Rovner et al. [64]and Kawamoto and Adelstein [39]showed that in 
addition to the two MHCs present in SM cells in vivo, there is a third MHC present in these cells in culture. This 
third form has been identified as a nonmuscle (NM) MHC by gel electrophoresis, Western blotting and peptide 
mapping 39, 64. These authors also reported that the expression of these three isoforms is regulated by the 
state of the cells in culture (i.e., confluent, quiescent cells have a high proportion of the SM isoforms, whereas 
nonconfluent, mitotic cells have a high proportion of the NM isoform). Seidel et al. [68]demonstrated that the 
NM MHC is not required for cytokinesis in these cultured cells and that the expression of SM1 and SM2 are co-
regulated. These findings are inconsistent with our hypothesis, suggesting division of labor for these isoforms 
with cell function (i.e., cytokinesis, synthesis and secretion of various compounds and cell migration by the NM 
MHCs vs contractile function by the SM MHCs). Grainger et al. [29]suggested that the accumulation of NM MHC 
may be necessary for cytokinesis, which would be consistent with the above stated hypothesis. 
Eddinger et al. [20]reported that there were, in fact, three MHC isoforms present in smooth muscle cells in vivo. 
Gel electrophoresis and Western blotting verified the third MHC as a nonmuscle isoform with similar 
electrophoretic and antigenic properties as the NM MHC isolated from platelets. In addition, identification and 
characterization of the LC20 protein from SM cells showed that there are also two isoforms of this protein 
expressed [26]. In mature swine carotid artery, the major form expressed is the SM LC20 and the minor isoform 
(approximately 16% of the total) is the NM LC20. This was verified by mass spectrometric analysis of tryptic 
peptides of blots of these proteins. The measured peptide masses correspond to published cDNA sequences 
proposed to represent SM and NM LC20 45, 74. The amount of the NM LC20 isoform (approximately 16%) is 
similar to the amount of NM MHC (approximately 14%) found in the swine carotid [26]. This agreement in 
relative content of the NM isoforms may result from limited isoform pairing of the native myosin molecule (i.e., 
only NM isoforms can combine to form a NM myosin molecule). 
A second, and possibly third, NM MHC isoform has also been reported in the literature. Mohammad and 
Sparrow [52]and Sartore et al. [67]observed a third MHC on SDS gels of human pulmonary artery that appears to 
be a unique NM MHC. Katsuragawa et al. [38]and Kawamoto and Adelstein [40]reported two distinct NM MHC 
mRNAs from chicken that show differential expression. Kawamoto and Adelstein [40]were also able to show two 
bands on SDS gels that were unique by two-dimensional peptide mapping. Simmons et al. [69]reported that the 
two human NM MHCs are encoded by two genes located on different chromosomes. Saez et al. [65]isolated a 
mammalian (human) NM MHC cDNA clone where alternative polyadenylation is used to generate multiple 
transcripts from the same protein. Murakami et al. [54]produced antisera for NM IIa and NM IIb from peptide 
sequences from human macrophages and bovine brain. These antisera distinguished between three distinct 
cellular (NM) MHC isoforms in the tissues surveyed. We resolved two unique NM MHCs in mouse uterus that 
can be distinguished from the SM MHC by antibody reactivity and distinguished from each other by 
electrophoresis and peptide mapping [19]. Thus, there are numerous data to support at least two, and possibly 
three, NM MHCs in a variety of tissues, including smooth muscle. 
Differences in LC17 have also been reported 9, 32, 33. In a report by Cavaille et al. [9], data are provided for the 
presence of two LC17 isoforms that change in ratio with pregnancy. Helper et al. [33]have shown that the 
presence of the two LC17 isoforms (LC17a and LC17b) is variable depending on the tissue, with the LC17a form 
representing as little as 35% of the total in rat aorta to as much as 100% of the total in swine digestive SM. It is 
interesting to note that in the swine carotid the minor isoform (LC17b) makes up approximately 16% of the total 
LC17 present. This is consistent with the 16% NM LC20 and 14% NM MHC reported to be present in this 
tissue [26]. Thus, it may be that the LC17b is also a “nonmuscle” isoform. 
An embryonic LC (LC23) has also been identified in chicken [73], rat [77]and human [12]. This isoform is present 
transiently during embryonic development and does not appear to be present in postnatal animals. 
These results have led to an ongoing controversy about the composition of the native myosin molecule in SM 
cells. Initial studies identifying the two SM MHC isoforms (SM1 and SM2) [64]reported a 1:1 ratio of these 
proteins in all tissues examined. Based on their data, the authors suggested that the myosin molecule formed an 
obligatory heterodimer relative to the heavy chains. This work was supported by the presence of a single myosin 
isoform on native (nondenaturing) gels where isoforms of skeletal (differing in MHC and/or LC composition) and 
cardiac (differing in MHC composition) myosin have been resolvable for many years 35, 36, 37. The lack of 
evidence for isoforms was further substantiated when Persechini et al. [60]showed that non-, mono- and 
diphosphorylated myosin (each differing by a single phosphate) were resolvable on this native gel system. 
Reports of isoforms of SM myosin on native gels, however, have been plagued with problems, stemming 
primarily from filamin, another large molecule that can co-migrate with myosin on these native 
gels [60](Eddinger, unpublished observations). Thus, the failure to observe isoforms can not be used as 
equivocal evidence that they do not exist. 
Numerous studies have since reported ratios other than 1:1 for the SM MHCs 5, 18, 46, 51. In addition, in high 
resolution gels the NM MHC can be separated from the SM2 isoform. Thus, the ratios of SM1:SM2 reported in 
the various studies where NM MHC is present but not identified are only accurate as to the amount of NM MHC 
isoform that is present in those tissues. It is now clear that the ratio of SM1:SM2 is not always 1:1, even when 
the NM MHC is taken into account [18]. The difference in the ratio of SM1:SM2 brings into question the 
hypothesis that these two MHC isoforms form an obligatory heterodimer in native myosin. 
We recently obtained evidence that the SM MHC from swine (aorta, stomach and uterus) and rabbit (stomach) 
forms three native smooth muscle isoforms with respect to their MHC composition [75]. In contrast to this, 
Kelley et al. [42]reported that bovine aortic smooth muscle myosin only forms homodimers. Kelley et al. used 
isoform-specific antibodies to immunoprecipitate myosin and for affinity chromatography. Use of the purified 
homodimers in in vitro motility assays showed no significant differences in their ability to move actin filaments. 
In addition, phosphorylation of the carboxyl terminal of SM1 was reported to have no effect on filament 
formation, ability to move actin filaments, actin-activated Mg2+ ATPase activity or molecule confirmation [41]. 
The reason for the difference between their results and ours may be due to the different species used for the 
experiments. 
Further work in this area has revealed that the three MHC isoforms are developmentally regulated 5, 17, 46. The 
developmental regulation of the MHC helps to explain some of the variability between the reports in the 
literature in which researchers have found seemingly inconsistent results. It does not, however, explain all the 
discrepancies, and it greatly increases the complexity of the system. We observed that in a wide variety of SM 
tissues from swine, rat and guinea pig, all three MHC isoforms are always present 20, 26. Others reported that 
this is not the case for several other tissues: rabbit aorta 5, 46and swine trachea [52]. In this last study, however, 
no evidence is provided that the antibody used to detect NM MHC reacts with swine NM MHC. This may be a 
problem because the monoclonal antibodies we generated proved to be species specific [16]. 
The developmental regulation of the expression of these MHC isoforms is not as simple as it might appear. 
Earlier work showed that the NM and SM MHC isoforms quantitatively change in cultured cells with cell 
cycle 5, 46, 52. We 16, 18and others 5, 46, 52reported a larger percentage of the NM MHC in young animals 
than in adults. These changes, however, do not fit a simple pattern. In most tissues from a variety of species, NM 
MHC content is very high in young animals and decreases as the animal develops. The decrease in NM MHC 
content, however, can be replaced by an increase in either SM1 (rat aorta) or SM2 (swine carotid) [18]. 
Numerous exceptions and variations of these changes occur. McConnell et al. [49]also reported a similar change 
for the SM MHC isoforms in rabbit bladder with development but did not quantify the NM MHC isoform. 
Mohammed and Sparrow [52]reported a smaller change in swine trachea for the SM1:SM2 ratio (decrease from 
2.1 to 1.0). Their young swine were 30–60 kg or 12–20 weeks. The young animals used by Eddinger and 
Murphy [17]were approximately 2 kg, 3–5 days. This could explain why their SM1:SM2 ratio in young animals is 
much lower than what we observed. It is also possible that this difference is due to variability between tissue 
types. Mohammad and Sparrow [52]reported no NM MHC present in the swine trachea and neither Borrione et 
al. [5]nor Kuro-o et al. [46]reported NM MHC in adult rabbit aorta. In addition, Giuriato et al. [28]reported that 
rabbit aorta shows cell-specific developmental changes in the myosin isoforms between the luminal and 
adventitial sides of the vessel. Thus, although there is substantial evidence for a change in SM MHC isoform 
content with development, the actual pattern of change can vary greatly. 
This variability in myosin subunits allows for the possibility of regulatory control and division of labor within and 
between SM cells. Quantitatively, the concentration of NM MHC and LC20 that is present in smooth muscle cells 
is 2- to 3-fold greater than that of platelets, Acanthamoeba or adrenal medulla [26]. This large quantity of 
protein would be expected to have some physiological significance. This may represent the greater capacity of 
the SM cell for synthesis, secretion, migration and proliferation [79]. 
Evidence suggests that these myosin isoforms may have discrete localization in SM cells. Small et 
al. [70]described two domains in smooth muscle cells (a contractile domain including myosin and caldesmon and 
a cytoskeletal domain including filamin and desmin) based on immunohistochemistry. Giuriato et al. [28]found 
unique distributions for the NM myosin isoforms in cultured aorta smooth muscle cells. One population is 
diffusely distributed throughout the cell, whereas another is localized to the cortical cytoplasm. In addition, 
DeNofrio et al. [14]reported that NM actin is present in membrane ruffles, pseudopods and stress fibers of 
pericytes, whereas SM actin is localized in stress fibers. Sartore et al. [66]stated that SM cells grown in 
vitro show a differential distribution of SM MHC isoforms among cells and a distinct localization of SM1 and SM2 
within the same cell. Sparrow and Mitchell [71]found changes in myosin expression, Ca2+-force relationship and 
pharmacological responsiveness of intact swine airway smooth muscle with development. In addition, cells that 
lack most of a specific myosin isoform have been shown to be incapable of cell division 13, 44. Thus, it is not 
totally unfounded to suggest a physiological significance for these various forms. 
In addition to the MHC differences in the tail region, differences have also been identified in the S1 myosin head 
region. These result from alternate splicing in the 5′ region 1, 30, 43, 78. This alternate splicing at the 25- to 50-
kDa junction in the S1 head region generates a seven amino acid insert in SM MHC from visceral tissue that are 
not present in tonic vascular tissue 1, 30, 43, 78. The presence of the insert in the head region (intestinal 
myosin) correlates with a higher velocity of movement of actin filaments in vitro and higher actin activated Mg2+-
ATPase activity than in vascular myosin (aorta) [43]. There are still species differences and other myosin subunit 
isoforms that confound these results. Increasing the LC17a content in the vascular myosin (no head insert) did not 
increase its ability to move actin filaments to the rate of the intestinal myosin (having head insert) [43], whereas 
Hasegawa and Morita [31]reported that a similar exchange in swine aortic myosin increases ATPase activity. The 
presence or absence of the head insert is associated with the SM1 MHC in rat [78](SM2 was not examined) is 
only associated with SM2 in the rabbit [1]and is associated with both SM1 and SM2 in turkey [43]. 
Fig. 2 shows a schematic representation of the possible combinations for the SM MHC. Fig. 2A shows the single 
SM MHC gene with the optional exons whose alternate splicing is responsible for the four possible mRNAs (Fig. 
2B). These four RNAs can be translated to generate four different SM MHC polypeptides (Fig. 2C). Fig. 2D shows 
the possible SM MHC pairings that can result in four MHC homodimer and six MHC heterodimer molecules. As 
discussed above, the tail isoforms (3′ end) include homo- and heterodimer molecules. Evidence for or against 
the head isoform (5′ end) MHC pairings is not available. 
Sparrow et al. [72]and Hewitt et al. [34]reported small positive correlations between SM1 MHC content 
and Vmax in rat myometrial tissue. In contrast, others have shown that Vmax correlates with LC17a content and not 
the SM1:SM2 MHC ratio in rat uterus [53]. Thus, the possible functional significance of these isoforms continues 
to be unresolved. Studies using tissues composed of cells showing a mixture of myosin isoforms confound 
mechanical studies. Using single smooth muscle cells for biochemical and mechanical studies will allow 
investigators to address these questions without the confounding mixtures of heterogeneous cells. 
As mentioned, there are reports of unique function for the presence or absence of the MHC head 
differences [43], ratio of SM MHC 34, 72and the ratio of LC17a [53]. Other implications for functional diversity 
within a vessel have also been suggested in a host of studies. Garland and Keatinge 24, 25reported different 
responses of the inner and outer muscle layers of vessels to various pharmacological agents. Although a 
significant portion of this variability can be attributed to the variation in innervation and the regional presence 
of other cell types in the vessel, these results are also consistent with unique SM cell function. Little et 
al. [48]reported unique homo- and heterocellular connections within the cell wall (endothelial–endothelial, SM–
SM and endothelial–SM cell junctions). They observed junctions between the endothelial–SM cells showing 
preferential communication in one direction (endothelial → SM). This may be of significance for in vivo function 
but may also hinder clarifying isoform function in whole tissue experiments. 
It has generally been assumed that the smooth muscle cell (SMC) population of the medial layer of the vessel 
wall is a homogeneous population of cells 8, 10. This does not presume that all SMCs are uniform at any given 
time, however. SMCs are believed to undergo phenotypic modulation when under specific environmental cues. 
This shift can vary from a highly differentiated state where the cells' primary function appears to be contraction 
to a nondifferentiated state where the cells are not contractile but rather active in synthesis, secretion and cell 
division. This range of phenotypic modulation has been observed in tissue culture where a variety of conditions 
were shown to shift SMCs back and forth between these extremes. 
Numerous reports in the literature indicate distinct SMC populations in the vessel wall [e.g., 23, 80]. These are 
often based on the presence or absence of the various contractile protein isoforms or morphological changes 
observed during development, disease or when the cells are cultured. Indeed, these changes may be the result 
of different populations of SMCs present in the tissue. These changes may also be a single population of SMCs 
that are moving back and forth along a continuum between a “dedifferentiated” synthetic/mitotic state and a 
“differentiated” contractile state. The difference here is an important point. In a “normal” vessel, there will be 
cell turnover with the resultant breakdown of senescent cells and mitosis of other cells for their replacement. 
Thus, one would expect to find distinct “populations” of SMCs in all vessels. The question is if these are distinct 
populations of cells or a single population of cells showing different phenotypes along a developmental 
continuum. 
Primary culture SMCs plated at low density rapidly change from an “SMC” into something morphologically and 
biochemically different than an “SMC.” However, if they are left in culture until they reach confluence, they 
change again (both morphologically and biochemically) to something again resembling “SMCs.” Repeated 
subculture often changes these SMCs into multiple populations of cells that can be distinguished by a number of 
attributes [58]. It is unclear, however, that the populations of SMCs after multiple platings are not from multiple 
cell types from the primary culture. In addition, many researchers agree that cells kept in culture for numerous 
platings are no longer the same as the cells that were put into culture. Thus, these differences may be due to a 
single population of cells that are in their various roles or multiple populations of cells. Unfortunately, these 
types of experiments may not resolve this question. 
As has been reported by others 23, 28, 80, there is a nonhomogeneous distribution of smooth muscle cells in the 
vascular wall. Thus, any attempt to assign functional roles to the various MHC must be done at the single cell 
level. This may explain in part why experiments designed to address this question at the tissue level have 
resulted in ambiguous results. Measurements made on preparations composed of nonhomogeneous 
populations of cells can lead to an averaging effect that would mask true correlations. Single cell experiments 
where protein isoform content and mechanical properties can be measured in the same cell are desirable to test 
for functional correlations with protein isoforms. 
We have tested several methods for determining the relative content of SM1 and SM2 in single cells. Standard 
protocols for separating and quantitating protein isoforms from tissues were attempted using enhanced 
sensitivity for detecting the proteins. Using silver staining of gels, we were able to visualize actin and myosin 
from swine stomach homogenates loaded at 0.1 and 10 ng wet weight tissue, respectively. Using an estimate of 
30–50 mg actin and 15 mg myosin/g wet weight tissue [55], it is calculated that this method can detect actin at 
3–5 pg and myosin at 150 pg. Unfortunately, this is not enough to be useful at the single cell level. 
Using polyclonal antibodies with the enhanced chemiluminescence (ECL, Amersham, Arlington Heights, IL), we 
were able to significantly increase the sensitivity of the assay. This method allows detection of myosin down to 
0.1 ng wet weight tissue loaded or 1.5 pg MHC. When single SMCs suspended at a density of 1 cell/μl are loaded 
onto gels, this method can detect MHC at loadings down to 1 μl, or the equivalent MHC protein from a single 
cell. Thus, this method may be useful for relative quantitation of protein isoforms from single SMCs. Using 
colloidal gold (Aurodye, Forte, Amersham) with their silver enhancer was not found to be as sensitive as the ECL. 
Although using gel electrophoresis is a viable method for resolving MHC protein isoforms and ECL appears to 
allow visualization of these isoforms from a single cell, we were interested in a technique that would be 
applicable over a larger range of proteins with a greater sensitivity. For example, MHC head difference isoforms 
are not resolvable by standard gel methods. We therefore turned to molecular techniques, which would 
theoretically allow relative quantitation of the various protein isoforms from single SMCs. 
Reverse transcription-polymerase chain reaction (RT-PCR) has been reported to provide the requisite specificity 
and sensitivity to be useful in analysis of protein isoforms from single cells 22, 47, 62. The known smooth 
muscle-specific MHC isoforms are all generated from a single gene through alternative splicing mechanisms. The 
first two smooth muscle-specific MHC isoforms discovered were SM1 and SM2 [63]. The difference between 
these two isoforms occurs in the 3′ nonhelical domain near their carboxyl termini. Identification of the tail 
difference region between SM1 and SM2 was obtained by sequencing two cDNAs derived from a rabbit uterine 
cDNA library that codes for the 3′ ends of SM1 and SM2 56, 57. Using genomic sequencing and RNase protection 
assays, it was shown that this difference resulted from an alternate splicing mechanism [2]. The difference 
results from alternative inclusion/exclusion of a 39 nucleotide exon with an inframe stop codon [2]. Inclusion of 
this exon produces the transcript for the SMC protein that has 9 unique amino acids and is 34 amino acids 
shorter than SM1 (Fig. 3). Oligonucleotide primers (20 mers) were designed from the known sequence of rabbit 
smooth muscle myosin [3]to flank the unique exon present in one of the smooth muscle myosin isoforms (SM2). 
Because the sequence on the mRNA is identical in the region upstream and downstream from this alternate 
splice site, the same set of primers binds to the 3′ and 5′ end of the alternate splice site in both the SM1 and 
SM2 mRNA (Fig. 3). These primers are used in a PCR to amplify specific regions of cDNA sequence. Because the 
primers flank an alternative splice site [2], the DNA fragments generated by PCR (PCR products) should be of two 
sizes, equal to the distance between the primer sites in the two isoforms (SM1 and SM2). The predicted sizes of 
the PCR products for the SM1 and SM2 myosin isoforms are 291 and 330 bp, respectively. 
Conversion of mRNA to cDNA in RT can be accomplished using either Oligo (dT) primers or random hexamers. 
The difference between SM1 and SM2 is at the 3′ end, close to the poly A tail. As might be expected, we have 
found that the oligo (dT) primers give a better yield of cDNA for the sequences of interest. PCR amplifies the 
sequences of interest logarithmically until the number of product sequences reaches a point when there are not 
enough primers to pair with all the product. During this plateau, phase amplification continues at something less 
than a logarithmic rate but does not alter their relative ratio. The number of products produced, their size and 
their quantity can be determined by running the sample on a gel and visualizing the bands with ethidium 
bromide followed by densitometric analysis. 
To obtain single cells, most isolations most often use a mixture of collagenase and elastase for tissue disruption 
and cell isolation. We tried these methods and found the cells isolated in this fashion are shorter on average 
than those obtained using a papain digestion as described by Driska and Porter [15]. The difference is most likely 
due to variant Ca2+ levels in the single cells during these two procedures. Cells from both isolations contract to 
stimulation with either high K+, histamine or phenylephrine. Using the longer cells provides extra length for 
attachment to pipettes for mechanical measurements. This is not critical, however, as other laboratories making 
mechanical measurements on single smooth muscle cells use a collagenase-elastase digestion [6]. 
To verify that the mRNA levels for SM1 and SM2 can be measured in an accurate and reproducible fashion and 
that the levels correspond with the protein levels in the cell, numerous controls are required. There are 
currently no methods that allow quantitation of the SM1 and SM2 protein levels from single cells. Although PCR, 
in theory, will allow quantitation of these message levels, it needs to be shown that there is some correlation 
between the mRNA level and the proteins expressed if PCR is to be used to infer relative protein ratios. This was 
done by using paired tissue samples from five different tissues (i.e., aorta, bladder, carotid, stomach and uterus), 
all of which express different ratios of SM1:SM2 MHC proteins. By isolating smooth muscle from each of these 
tissues, we were able to obtain SM2:SM1 protein ratios that varied from approximately 0.1–1.1. These tissues 
were isolated and cleaned of blood, adipose, loose connective tissue and nonmuscle layers (endothelium, 
mucosa, endometrium or transitional epithelium). Isolated smooth muscle tissue from each preparation was 
then homogenized in sample buffer and run on SDS-PAGE to isolate and quantitate the two SM MHC isoforms. 
Adjacent smooth muscle tissue from each preparation was homogenized in buffer for total RNA extraction. RT-
PCR was then used to generate cDNA and amplify fragments specific for the SM1 and SM2 mRNA. These 
products could also be run on SDS-PAGE to isolate and quantitate the products amplified. 
Because we are using a single set of primers that bind to identical sequences on both SM1 and SM2 cDNA, the 
binding efficiencies are the same. The SM1/SM2 PCR primers flank intervening sequences in genomic DNA [2]so 
that only cDNA produces correctly sized PCR products. The amplicons are identical with the exception of the 39 
additional nucleotides present in the SM2 cDNA. As has been reported by others [27], there is no difference in 
amplification of amplicons that use identical primers but differ by a small unique nucleotide sequence. The size 
difference between the two amplicons allows their separation on SDS-PAGE. The amount of product produced 
for each sequence is a function of the initial cDNA concentration, which is a function of the levels of mRNA 
present in the tissue. Thus, quantitation of the two bands (SM1 and SM2 cDNA) from the gel gives the relative 
ratio of SM1 and SM2 mRNA present in the starting tissue. 
Only two bands are observed on the SDS-PAGE gels when the RT-PCR reaction products are run (Fig. 4). The 
bands were identified by their predicted sizes (291 and 330 bp) by selective enzymatic digestion and by 
sequencing. Approximately 200 bp of each band has been sequenced, including the difference region, showing a 
perfect match with their published sequences [3]. Because no other bands are observed, the data are not 
confused by primer dimerization. 
Quantitation of the relative levels of SM2:SM1 mRNA and SM2:SM1 protein from 48 pairs of adjacent tissue 
regions of five smooth muscle tissues from 17 rabbits gave a correlation coefficient R value of 0.92. This large 
sample size and high R values suggest that the expressed protein levels of SM1 and SM2 MHC are regulated 
primarily by alternative splicing as has been suggested 2, 3. It also suggests that the SM2:SM1 mRNA ratio is a 
good measure of the SM2:SM1 protein ratio. This is important as there is no method currently available to 
detect MHC protein levels at the single SMC level, whereas RT-PCR, in theory, is capable of determining the 
SM2:SM1 mRNA level in single SMCs. 
Although there have been reports in the literature of using RT-PCR on single cells 47, 61, we are unaware of 
anyone having done so with single smooth muscle cells. As mentioned above, SM-MHC provide an ideal system 
because they allow a single set of primers to be used for their amplification. Theoretically, relative quantitation 
is possible because all of the criteria required for quantitation of PCR products are met in this 
system 11, 21, 22, 27, 59, 76. We have done numerous controls to verify that in actuality this is the case for 
amplification of SM1 and SM2 mRNA from single cells using a single set of primers that span the 3′ alternate 
splice site. 
The specificity of the reaction is indicated by the presence of only two amplified products on the gels for all 
smooth muscle tissue used (vascular, digestive, reproductive, urinary). This is true even when using 60 cycles to 
amplify low numbers of copies (Fig. 4). Negative controls, which show no product after PCR, also verify the 
specificity. Leaving RNA out of the RT reaction or leaving cDNA out of the PCR reaction both resulted in no 
products being amplified. 
The accuracy of the reaction was confirmed by control experiments using known quantities of purified SM1 and 
SM2 cDNA in a variety of ratios for the PCR reaction. SM2 and SM1 DNA were mixed to give ratios of 0, 25, 50, 
75 and 100% SM2. PCR was performed on these mixtures and quantitation done on the resulting products. PCR 
using 35 cycles of amplification on approximately 10−9 g starting DNA or 60 cycles of amplification starting with 
approximately 10−18 g DNA both generated products with SM2:SM1 ratios not significantly different than the 
original ratio. Loading and quantitation of a 16-fold concentration range of PCR product from a gel gave a linear 
regression for the band intensities of R > 0.98. This indicates that the measurements are being made in a 
quantifiable loading range. 
The reproducibility and sensitivity of the RT-PCR method were shown by several more control experiments. 
Duplicate RT reactions performed using RNA from the same total RNA extraction samples yielded PCR-amplified 
SM2:SM1 RNA ratios that were not significantly different (n = 6, paired t-test, P < 0.05). The control for accuracy 
described above indicated that the method can accurately amplify a sequence when starting with as little as an 
estimated 600 copies of cDNA (10−18 g) or the number of copies expected to be present in a single cell. Isolated 
single SMCs can also be used for the RT-PCR. The cells are picked up using a glass micropipette and transferred 
into a microcentrifuge tube. The RT reaction is performed on the whole cell lysate to prevent possible loss or 
selective extraction of RNA during standard RNA extraction techniques. Reproducibility and sensitivity of the 
method can be most clearly observed from a split single cell control. RT reactions were done on isolated single 
SMCs, which were then split in half so that duplicate PCR reactions could be performed. Two bands (SM2, 330 
bp; SM1, 291 bp) were observed for each “split cell” after PCR. The SM2:SM1 ratio for each split cell reaction 
was not significantly different (n = 11, paired Student's t-test, P < 0.05). Thus, RT-PCR works reproducibly on the 
equivalent of one-half of the SM MHC mRNA from a single smooth muscle cell. [50]. 
Rabbit carotid tissue samples show a SM2:SM1 MHC protein ratio of approximately 0.5. The SM2:SM1 MHC 
mRNA ratio for this tissue is also approximately 0.5. Single smooth muscle cells isolated from this tissue also 
show an average SM2:SM1 mRNA ratio of approximately 0.5. However, the individual cells show a range of 
SM2:SM1 mRNA ratios from 0.0 to 1.8. This is in contrast to the variability observed at the tissue level for these 
same tissues that ranged from 0.43 to 0.56. The individual cells show a range of variability that is not observed 
at the tissue levels, even during perinatal development or in disease states. 
The range of SM2:SM1 ratios exhibited by smooth muscle cells isolated from the same carotid is very broad 
relative to the age-matched interanimal variability of vascular tissue SM2:SM1 ratios. Also, the single cell 
SM2:SM1 ratio range always encompasses the SM2:SM1 ratio of the tissue from which the cells were isolated. 
Therefore, by studying the mechanical properties of multicellular smooth muscle preparations, an averaging of 
the contributions of smooth muscle cells with different SM2/SM1 complements occurs, possibly obscuring 
unique functional characteristics of these isoforms. These functional differences may also be obscured during in 
vitro motility assays that examine single myosin molecules outside their native filaments. Biochemical studies 
using purified proteins would not show differences either, unless the amounts of these isoforms were controlled 
for and their spatial arrangements that exist in vivo were duplicated. Ribonuclease protection assays have been 
used to measure expression of smooth muscle-specific MHC of the mRNA level 2, 4. However, RNase protection 
assays are not sufficiently sensitive to detect mRNA from a single smooth muscle cell. Thus, to determine 
whether the smooth muscle-specific MHC isoforms SM1 and SM2 (or any of the other myosin polypeptide 
isoforms: MHC-head, LC20, LC17) have unique physiological roles, the expression levels of SM2 and SM1 in single 
cells with known mechanical properties must be determined. 
 
Fig. 1. Schematic representation of the SM myosin molecule. The protein is a hexamer consisting of two MHCs 
and four LCs. Limited proteolytic digestion with specific enzymes results in MHC fragments as indicated by the 
dashed lines (LMM, light meromyosin; S2, subfragment 2; S1, subfragment 1). The unique differences between 
the two MHCs occur at the carboxyl terminal non-helical tail (tail insert) and at the S1 head region (head insert). 
One LC20 and one LC17 associate with each MHC head. There are at least two isoforms of each of these LCs. 
 
Fig. 2. Schematic flow diagram for possible SM MHC molecule pairing. (A) Single SM MHC gene with 5′ and 3′ 
exon and introns indicated as boxes and lines. Dashed line indicates sequence not shown. (B) Four possible SM 
MHC mRNA can result from exclusion or inclusion of the alternatively spliced exons responsible for the head 
insert (5′ end) and the tail insert (3′ end). (C) Each mRNA may be translated to form a unique SM MHC 
polypeptide. (D) Possible pairing of the four SM MHCs to form unique myosin molecule isoforms (light chains are 
not included to minimize confusion). All four SM MHCs may not exist in all SM tissues and, thus, these 
combinations may not be possible in all tissues. 
 
Fig. 3. Schematic drawing of 3′ end of SM MHC gene showing alternative splice options. Splice option one 
includes the alternative exon and the resulting mRNA is shown in lower left (SM2). Splice option two excludes 
the alternate exon and the resulting mRNA is shown in the lower right (SM1). Although the SM2 mRNA message 
is longer than the SM1 mRNA message, the SM2 protein is shorter than the SM1 protein due to a stop codon 
present in the alternative exon. Primer locations are denoted by asterisks. Primer brining sites are in common 
between both the SM2 and SM1 mRNA and thus generate two different sized products, depending on the 
presence or absence of the alternative exon. 
 
Fig. 4. Eight percent SDS polyacrylamide gel showing RT-PCR products from rabbit carotid tissue (lane 6) and 
isolated single cells from the same vessel (lanes 2–5). Lane 1 shows 123 bp marker (bands 123–452 shown). For 
isolated cells and tissues, the upper band (when present) is SM2 mRNA (330 bp) and the lower band is SM1 (291 
bp). The tissue sample (lane 6) shows an SM2:SM1 ratio of 0.43 and the four isolated single cells obtained from 
an adjacent piece of tissue show SM1:SM1 ratio from 0.02 (lane 2) to 0.66 (lane 3). 
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